help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fallucca, F.
Right arrow Articles by Maldonato, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fallucca, F.
Right arrow Articles by Maldonato, A.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 137-139, Copyright © 1996 by Endocrine Society

ARTICLES

Amniotic fluid insulin and C peptide levels in diabetic and nondiabetic women during early pregnancy

F Fallucca, E Sciullo, A Napoli, G Cardellini and A Maldonato
Diabetes Unit-CIMS, Institute Clinica Medica 2, La Sapienza University, Rome, Italy.

Thanks to the widespread use of amniocentesis, glucose, insulin, and C peptide have often been measured in amniotic fluid (AF) during late gestation, but little is known about their concentrations during early pregnancy. To better understand early fetal beta-cell function under normal conditions and in the presence of maternal diabetes, we measured glucose, insulin, and C peptide in the AF collected during weeks 15-22 in 77 healthy and 9 diabetic women undergoing amniocentesis for clinical indications and compared the results with those obtained during late pregnancy (weeks 34-36). The AF C peptide concentration was higher in diabetic women (102 +/- 53 vs. 38 +/- 2 pmol/L), in the women with a family history of diabetes (41 +/- 6 vs. 35 +/- 2 pmol/L), after the 19th week of gestation (46 +/- 5 vs. 35 +/- 2 pmol/L; in the presence of lower glucose concentrations), and in the presence of maternal plasma glucose levels greater than 5.56 mmol/L (42 +/- 3.5 vs. 34 +/- 2 pmol/L). The comparison between early and late gestation showed decreasing glucose and increasing C peptide concentrations in both healthy and diabetic women (in the latter, C peptide values were always 3 times higher), whereas the insulin concentration was increased in late gestation only in diabetic women. The AF C peptide/insulin molar ratio increased throughout pregnancy in both healthy (from 0.97 +/- 0.06 to 4.3 +/- 1.2) and diabetic (from 2.9 +/- 1.1 to 13.2 +/- 1.6) women. These parallel changes suggest that the fetal clearance and/or degradation of insulin and C peptide may greatly change during both normal and diabetic gestation.


This article has been cited by other articles:


Home page
 Diabetes CareHome page
M. W. Carpenter, J. A. Canick, J. W. Hogan, C. Shellum, M. Somers, and J. A. Star
Amniotic Fluid Insulin at 14-20 Weeks' Gestation: Association with later maternal glucose intolerance and birth macrosomia
Diabetes Care, July 1, 2001; 24(7): 1259 - 1263.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
F. FALLUCCA, A. SABBATINI, N. DI BIASE, E. BORRELLO, A. NAPOLI, and E. SCIULLO
Fetal Pancreatic Function in Infants of Diabetic and Rhesus-Isoimmunized Women
Obstet. Gynecol., February 1, 2000; 95(2): 195 - 198.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society